138 results
Page 4 of 7
8-K
EX-99.1
101mns9o3t
8 Jul 20
Akers Biosciences and Premas Biotech Announce Initiation of Animal Studies
11:48am
8-K
EX-99.1
uf51bu7h
19 May 20
Akers Biosciences Closes $4.8 Million Registered Direct Offering
12:00am
424B5
vdtrokidqr0v2j 9vzv
18 May 20
Prospectus supplement for primary offering
6:07am
8-K
EX-99.2
7qboiac 7rbdjn2t
15 May 20
Entry into a Material Definitive Agreement
8:18am
8-K
EX-10.1
1t4fumg
15 May 20
Entry into a Material Definitive Agreement
8:18am
8-K
EX-99.1
dsisa8mlpcq bqr
14 May 20
Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP
1:00pm
8-K
EX-99.1
rxhp5 4ddzgr8qsc58h
14 Apr 20
Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens
9:20am
424B5
cxhinbbnnfd
8 Apr 20
Prospectus supplement for primary offering
9:16am
8-K
EX-99.2
ooku p0kdl6b
8 Apr 20
Entry into a Material Definitive Agreement
6:21am
8-K
EX-99.1
kwf4ek 0dm1b
8 Apr 20
Entry into a Material Definitive Agreement
6:21am
8-K
EX-99.1
gvx8ipbyd0nwf
7 Apr 20
Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19
10:05am
8-K
EX-10.4
14w119
24 Mar 20
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
9:21am
8-K
EX-3.1
ulqj3 pwr
24 Mar 20
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
9:21am